GEN: financial statements from SEC

Income statement

Metric	Mar 31, 2026	Mar 31, 2025
Revenue	5.00bn	3.94bn
Cost of revenue	1.08bn	776m
Gross profit	3.92bn	3.16bn
Research and development	409m	329m
Selling, general and administrative	—	291m
Operating expenses	1.80bn	1.55bn
Operating income	2.12bn	1.61bn
Pre-tax income	1.51bn	1.03bn
Income tax	538m	386m
Net income	973m	643m
Earnings per share	1.59	1.04
Earnings per share, diluted	1.57	1.03
Weighted average shares	612m	617m
Weighted average shares, diluted	619m	624m

Metric	Mar 31, 2026	Dec 31, 2025	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024
Cash and equivalents	411m	619m	701m	828m	1.01bn	883m	737m	644m
Receivables	361m	361m	309m	314m	171m	152m	164m	152m
Current assets	1.08bn	1.25bn	1.29bn	1.43bn	1.44bn	1.32bn	1.22bn	1.11bn
Property, plant and equipment	71m	69m	68m	64m	60m	61m	60m	69m
Goodwill	11.00bn	10.85bn	10.83bn	10.82bn	10.24bn	10.17bn	10.24bn	10.21bn
Total assets	15.59bn	15.83bn	16.05bn	16.36bn	15.50bn	15.36bn	15.47bn	15.43bn
Current liabilities	2.71bn	2.69bn	2.55bn	2.86bn	2.85bn	3.76bn	3.82bn	3.75bn
Short-term debt	181m	240m	280m	288m	291m	1.40bn	1.39bn	1.33bn
Long-term debt	8.02bn	8.17bn	8.42bn	8.58bn	7.97bn	7.08bn	7.14bn	7.19bn
Total liabilities	12.98bn	13.50bn	13.59bn	14.00bn	13.23bn	13.21bn	13.37bn	13.46bn
Equity	2.61bn	2.33bn	2.46bn	2.37bn	2.27bn	2.15bn	2.10bn	1.97bn
Shares outstanding	598m	606m	617m	616m	617m	616m	616m	615m
Shares issued	598m	606m	617m	616m	617m	616m	616m	615m

Metric	Mar 31, 2026	Mar 31, 2025
Operating cash flow	1.55bn	1.22bn
Depreciation and amortisation	493m	419m
Share-based compensation	237m	133m
Capital expenditure	22m	15m
Investing cash flow	−1.01bn	−100m
Dividends paid	312m	313m
Share buybacks	634m	272m
Financing cash flow	−1.13bn	−970m